Paper40649366
Hydrazides as Powerful Tools in Medicinal Chemistry: Synthesis, Reactivity, and Biological Applications.
Teixeira S and 2 others. Molecules, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Hydrazides as Powerful Tools in Medicinal Chemistry: Synthesis, Reactivity, and Biological Applications. Papers, record 40649366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40649366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hydrazides as Powerful Tools in Medicinal Chemistry: Synthesis, Reactivity, and Biological Applications.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydrazines | Major topic |
| Chemistry, Pharmaceutical | Major topic |
| Humans | |
| Hydrazones | |
| Molecular Structure |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Strategic Funding of CF-UM-UP (UIDB/04650/2020) | Fundação para a Ciência e a Tecnologia (FCT - Portugal) | PubMed | ||
| Strategic Funding of CQUM (UIDB/00686/2020) | Fundação para a Ciência e a Tecnologia (FCT - Portugal) | PubMed | ||
| PTDC/MED-ONC/31354/2017 | FEDER/FCT | PubMed | ||
| PTDC/SAU-PAR/2766/2021 | FEDER/FCT | PubMed | ||
| 2020.04975.BD | Fundação para a Ciência e a Tecnologia (FCT - Portugal), FSE (Fundo Social Europeu) through "Programa Operacional Regional Norte" | PubMed |
Source PubMed
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36251201 | Synthesis of new 3-acetyl-1,3,4-oxadiazolines combined with pyrimidines as antileishmanial and antiviral agents. | Mol Divers | 2023 | https://conductscience.org/library/papers/36251201 | PubMed |
| 2 | 36557829 | 2,5-Bis(2,2,2-trifluoroethoxy)phenyl-tethered 1,3,4-Oxadiazoles Derivatives: Synthesis, In Silico Studies, and Biological Assessment as Potential Candidates for Anti-Cancer and Anti-Diabetic Agent. | Molecules | 2022 | https://conductscience.org/library/papers/36557829 | PubMed |
| 3 | 32806177 | Direct Catalytic Symmetrical, Unsymmetrical N,N-Dialkylation and Cyclization of Acylhydrazides Using Alcohols. | Org Lett | 2020 | https://conductscience.org/library/papers/32806177 | PubMed |
| 4 | 36105346 | Stereoisomers of an Aryl Pyrazole Glucocorticoid Receptor Agonist Scaffold Elicit Differing Anti-inflammatory Responses. | ACS Med Chem Lett | 2022 | https://conductscience.org/library/papers/36105346 | PubMed |
| 5 | 33317840 | Probing phenylcarbamoylazinane-1,2,4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies. | Bioorg Chem | 2021 | https://conductscience.org/library/papers/33317840 | PubMed |
| 6 | 36634456 | Design, synthesis, and biological activity studies on benzimidazole derivatives targeting myeloperoxidase. | Eur J Med Chem | 2023 | https://conductscience.org/library/papers/36634456 | PubMed |
| 7 | 30079136 | Amelioration of hepatotoxicity by biocleavable aminothiol chimeras of isoniazid: Design, synthesis, kinetics and pharmacological evaluation. | World J Hepatol | 2018 | https://conductscience.org/library/papers/30079136 | PubMed |
| 8 | 28770814 | Malaria. | Nat Rev Dis Primers | 2017 | https://conductscience.org/library/papers/28770814 | PubMed |
| 9 | 37748386 | Exploring novel anticancer pyrazole benzenesulfonamides featuring tail approach strategy as carbonic anhydrase inhibitors. | Eur J Med Chem | 2023 | https://conductscience.org/library/papers/37748386 | PubMed |
| 10 | 26725953 | Synthesis and antituberculosis activity of indole-pyridine derived hydrazides, hydrazide-hydrazones, and thiosemicarbazones. | Bioorg Med Chem Lett | 2016 | https://conductscience.org/library/papers/26725953 | PubMed |
| 11 | 35299769 | Synthesis and biological activity of 2-[6-methyl-4-(thietan-3-yloxy)pyrimidin-2-ylthio]acetohydrazide derivatives. | ADMET DMPK | 2021 | https://conductscience.org/library/papers/35299769 | PubMed |
| 12 | 31589462 | A Hydrazine Insertion Route to N'-Alkyl Benzohydrazides by an Unexpected Carbon-Carbon Bond Cleavage. | Org Lett | 2019 | https://conductscience.org/library/papers/31589462 | PubMed |
| 13 | 19059680 | Synthesis and pharmacological evaluation of 2(3H)-furanones and 2(3H)-pyrrolones, combining analgesic and anti-inflammatory properties with reduced gastrointestinal toxicity and lipid peroxidation. | Eur J Med Chem | 2009 | https://conductscience.org/library/papers/19059680 | PubMed |
| 14 | 30969447 | Hydrazide-Hydrazone Small Molecules as AIEgens: Illuminating Mitochondria in Cancer Cells. | Chemistry | 2019 | https://conductscience.org/library/papers/30969447 | PubMed |
| 15 | 38486498 | Visible-Light-Induced Siloxycarbene Addition to N═N of Azodicarboxylates: Synthesis of Acyl Hydrazides from Acylsilanes. | Org Lett | 2024 | https://conductscience.org/library/papers/38486498 | PubMed |
| 16 | 31694218 | Synthesis and Bioactivity of Hydrazide-Hydrazones with the 1-Adamantyl-Carbonyl Moiety. | Molecules | 2019 | https://conductscience.org/library/papers/31694218 | PubMed |
| 17 | 29071215 | The Different Mechanisms of Cancer Drug Resistance: A Brief Review. | Adv Pharm Bull | 2017 | https://conductscience.org/library/papers/29071215 | PubMed |
| 18 | 34240393 | Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively. | CNS Drugs | 2021 | https://conductscience.org/library/papers/34240393 | PubMed |
| 19 | 36116325 | Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studies. | Bioorg Chem | 2022 | https://conductscience.org/library/papers/36116325 | PubMed |
| 20 | 36950918 | Synthesis, biological evaluation and theoretical studies of (E)-1-(4-sulfamoyl-phenylethyl)-3-arylidene-5-aryl-1H-pyrrol-2(3H)-ones as human carbonic anhydrase inhibitors. | J Enzyme Inhib Med Chem | 2023 | https://conductscience.org/library/papers/36950918 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42832106 | Enhancing the Conjugation of Cyclotriphosphazene Covalent Organic Frameworks to Improve the Fluorescence Detection Performance of Hydrazine. | J Fluoresc | 2026 | https://conductscience.org/library/papers/42832106 | PubMed |
| 42035379 | Synthesis and molecular characterization of a novel FA-ADH-GMS conjugated pH-responsive lipid for targeted drug delivery. | Mol Divers | 2026 | https://conductscience.org/library/papers/42035379 | PubMed |
| 41813747 | New benzimidazole-alkanesulfonate conjugates as cholinesterase inhibitors with in vitro and in silico validation. | Sci Rep | 2026 | https://conductscience.org/library/papers/41813747 | PubMed |
| 41591272 | When Reality Defies Prediction: Polymorphism, Twinning, and Accordion Crystals. | J Am Chem Soc | 2026 | https://conductscience.org/library/papers/41591272 | PubMed |
| 41318660 | Synthesis and characterization of FeCuAlO4 as a reusable heterogeneous acidic nanocatalyst for preparation of 2-amino-1,3,4-thiadiazole derivatives in water. | Sci Rep | 2025 | https://conductscience.org/library/papers/41318660 | PubMed |
| 41272133 | Novel Triazole-Carbohydrazide hydrazones with dual antioxidant and antibacterial potential. | Sci Rep | 2025 | https://conductscience.org/library/papers/41272133 | PubMed |
| 41009403 | Catalyst-Free Assembly of δ-Lactam-Based Hydrazide-Hydrazone Compounds from 3-Arylglutaconic Anhydrides and Aldazines. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009403 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40649366
GET https://conductscience.org/api/papers/v1/40649366/references?page=2